Biotech Stock Pops After Cannabis Medicine Outsells Expectations

ALLISON GATLIN - finance.yahoo.com Posted 5 years ago

GW stock popped late Monday after the biotech's first-quarter sales beat estimates. GW also said cannabis medicine Epidiolex succeeded in a test of patients with tuberous sclerosis complex.

Story continues

ALLISON GATLIN - finance.yahoo.com Posted 5 years ago

More news for you:

GW Pharmaceuticals stock rises 6% after positive CBD drug trial

finance.yahoo.com Posted 06 May

How Marketers Use Redirect Ads to Deceive You

.Posted 20 Sep